Wetherby Asset Management Inc Boston Scientific Corp Transaction History

Wetherby Asset Management Inc

$2.04 Billion
Q4 2024

A detailed history of Wetherby Asset Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Wetherby Asset Management Inc holds 25,574 shares of BSX stock, worth $2.63 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,574

Previous 28,107 9.01%

Holding current value

$2.63 Million

Previous $2.36 Million 3.01%

% of portfolio

0.11%

Previous 0.11%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	SELL	$83.62 - $91.5 $211,809 - $231,769	-2,533 Reduced 9.01%	25,574 $2.28 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $42,024 - $48,384	576 Added 2.09%	28,107 $2.36 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $59,856 - $69,084	-889 Reduced 3.13%	27,531 $2.12 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $17,107 - $20,380	297 Added 1.06%	28,420 $1.95 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $1,118 - $1,329	-23 Reduced 0.08%	28,123 $1.63 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $21,732 - $23,676	433 Added 1.56%	28,146 $1.49 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $46,935 - $51,580	-944 Reduced 3.29%	27,713 $1.5 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $21,643 - $24,014	-480 Reduced 1.65%	28,657 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $26,386 - $31,495	667 Added 2.34%	29,137 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $22,172 - $66,234	604 Added 2.17%	28,470 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $73,193 - $97,826	2,077 Added 8.05%	27,866 $1.04 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $87,975 - $97,010	2,151 Added 9.1%	25,789 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $37,537 - $44,241	-986 Reduced 4.0%	23,638 $1 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $26,345 - $29,317	639 Added 2.66%	24,624 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $45,370 - $52,026	1,176 Added 5.16%	23,985 $1.03 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $3,456 - $3,887	-98 Reduced 0.43%	22,809 $881,000
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $747,565 - $946,465	22,551 Added 6334.55%	22,907 $824,000
Q3 2020 Dec 16, 2020	SELL	$34.44 - $42.23 $845,295 - $1.04 Million	-24,544 Reduced 98.57%	356 $14,000
Q3 2020 Dec 16, 2020	SELL	$34.44 - $42.23 $34,508 - $42,314	-1,002 Reduced 3.87%	24,900 $951,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $139,550 - $171,115	4,052 Added 18.54%	25,902 $990,000
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $10,294 - $13,336	-341 Reduced 1.54%	21,850 $768,000
Q1 2020 May 06, 2020	SELL	$25.83 - $45.71 $29,084 - $51,469	-1,126 Reduced 4.83%	22,191 $724,000
Q4 2019 Jan 28, 2020	BUY	$37.87 - $45.37 $72,028 - $86,293	1,902 Added 8.88%	23,317 $1.05 Million
Q3 2019 Oct 31, 2019	BUY	$40.31 - $43.45 $21,243 - $22,898	527 Added 2.52%	21,415 $871,000
Q2 2019 Jul 25, 2019	BUY	$34.91 - $42.98 $17,908 - $22,048	513 Added 2.52%	20,888 $898,000
Q1 2019 May 09, 2019	BUY	$32.91 - $40.75 $88,758 - $109,902	2,697 Added 15.26%	20,375 $782,000
Q4 2018 Jan 30, 2019	BUY	$31.73 - $39.04 $6,155 - $7,573	194 Added 1.11%	17,678 $625,000
Q3 2018 Nov 07, 2018	BUY	$32.83 - $38.63 $22,357 - $26,307	681 Added 4.05%	17,484 $673,000
Q2 2018 Jul 24, 2018	BUY	$26.84 - $34.32 $38,354 - $49,043	1,429 Added 9.29%	16,803 $549,000
Q1 2018 May 04, 2018	BUY	$25.2 - $28.54 $19,404 - $21,975	770 Added 5.27%	15,374 $420,000
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $15,444 - $18,565	623 Added 4.46%	14,604 $362,000
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $367,141 - $407,825	13,981	13,981 $408,000

Others Institutions Holding BSX

# of Institutions

1,792

Shares Held

1.21B

Call Options Held

8.32M

Put Options Held

7.2M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Boston Scientific Corp Transaction History